Article ID Journal Published Year Pages File Type
4285493 International Journal of Surgery 2016 7 Pages PDF
Abstract

•Focused ESWT needs to be applied only once in many cases.•None of the treatment parameters assessed relevantly affected outcome.•None of the anamnestic or sociodemographic parameters assessed affected outcome.•Treatment success was independent of the physician applying ESWT.•Further research should focus on the number of treatment sessions as well as the minimum energy flux density needed.

IntroductionExtracorporeal shockwave therapy (ESWT) is an established second-line treatment option for plantar fasciitis. Longer term results of focused ESWT are rare in literature. This study assessed the treatment success-rates of single session ESWT compared to repetitive ESWT treatment sessions, the mid-term results as well as treatment- or patient-related factors influencing the outcome of focused ESWT for plantar fasciitis.Methods284 patients (363 feet) received ESWT for plantar fasciitis and answered a questionnaire on socio-demographic and anamnestic data immediately before as well as 19–77 weeks after the first application of ESWT.Results76 percent of patients treated only once and 74 percent of all patients reported satisfying pain relief (with up to three treatment sessions). This was consistent in the mid-term and over different physicians as well as independent of assessed patient- or treatment-related factors.DiscussionApplying repeated ESWT in weekly intervals by default may be helpful in reducing healing time for those patients requiring more than one treatment session. Prospective research is needed to find out whether further treatment sessions are justifiable in patients who indicate no improvement after two or three treatment sessions.ConclusionsIn many cases, focused ESWT needs to be applied only once. Further research should focus on the number of treatment sessions as well as the minimum energy flux density needed.

Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , , , , , ,